0001752724-21-193804.txt : 20210909 0001752724-21-193804.hdr.sgml : 20210909 20210909104953 ACCESSION NUMBER: 0001752724-21-193804 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210909 DATE AS OF CHANGE: 20210909 EFFECTIVENESS DATE: 20210909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MFS SERIES TRUST XVI CENTRAL INDEX KEY: 0000063067 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-02032 FILM NUMBER: 211243800 BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVENUE STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 18006372929 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVENUE STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: MFS GROWTH OPPORTUNITIES FUND DATE OF NAME CHANGE: 19940304 FORMER COMPANY: FORMER CONFORMED NAME: MFS CAPITAL DEVELOPMENT FUND DATE OF NAME CHANGE: 19930408 FORMER COMPANY: FORMER CONFORMED NAME: MASSACHUSETT MFS CAPITAL DEVELOPMENT FUND DATE OF NAME CHANGE: 19921015 0000063067 S000059884 MFS Prudent Investor Fund C000195901 A FPPAX C000195903 B FPPDX C000195904 C FPPEX C000195905 I FPPJX C000195906 R1 FPPRX C000195907 R2 FPPSX C000195908 R3 FPPQX C000195909 R4 FPPUX C000195910 R6 FPPVX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000063067 XXXXXXXX 811-02032 true false false N-1A true MFS Series Trust XVI 811-02032 0000063067 5493008WCCG2JFMV6Z59 111 Huntington Avenue Boston 02199 US-MA US 617-954-5000 Charles River Development 700 District Avenue Burlington 01803 17812380099 Investment related records Institutional Shareholder Services Inc. 702 King Farm Boulevard Suite 400 Rockville 20850 13015560500 Proxy voting administrator The Depository Trust Company 55 Water Street New York 10041 12128551000 DTC JPMorgan Chase 270 Park Avenue New York 10017 12122706000 Custodian record Iron Mountain Inc. 1 Federal Street Boston 02110 18008994766 Storage Vendor DST Systems,Inc. 333 West 11thStreet Kansas City 64105 18164351000 Technology Vendor MFS Service Center Inc. 100 Hancock Street North Quincy 02171 16179545000 Transfer agency record MFS Fund Distributors,Inc. 111 Huntington Avenue Boston 02199 16179545000 Principal underwriter record Ropes&Gray 800 Boylston Street Boston 02199 16179517000 Counsel record TerraNua U.S. Corp d.b.a. My Compliance Office 535 5th Avenue 4th floor New York 10017 18669512280 Personal Trading System Autonomy Corporation Limited 1140 Enterprise Way Sunnyvale 94089 441223448000 Storage Vendor Massachusetts Financial Services Company 111 Huntington Avenue Boston 02199 16179545000 Investment adviser record N N N-1A 1 Y John A. Caroselli N/A N Maureen R. Goldfarb N/A N Laurie J. Thomsen N/A N Maryanne L. Roepke N/A N Clarence Otis, Jr. N/A N Robert J. Manning 004646484 Y James W. Kilman, Jr. N/A N Michael W. Roberge N/A Y Peter D. Jones N/A N Steven E. Buller N/A N John P. Kavanaugh N/A N Martin J. Wolin 004331075 111 Huntington Avenue Boston 02199 XXXXXX N N N N N N N MFS FUND DISTRIBUTORS, INC. 8-45321 000031052 N/A Y N DELOITTE & TOUCHE LLP 34 N/A N N N N N N MFS Prudent Investor Fund S000059884 549300GL4THNMBUGZH54 N 9 0 0 N/A N N Y N N JPMorgan Chase Bank N.A. 8I5DZWZKVSZI1NUHU748 N N Revenue sharing split Cash collateral reinvestment fee 19427.91000000 75.29000000 Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 22d-1 (17 CFR 270.22d-1) Y Y N N MASSACHUSETTS FINANCIAL SERVICES COMPANY 801-17352 000110045 1G3OSH3GLGJ7X1JC5I61 N MFS SERVICE CENTER, INC. 84-1316 N/A Y N N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N Refinitiv U.S. Holdings Inc. 5490300NF240HXJO7N016 N IHS Markit 549300HLPTRASHS0E726 GB N N JPMORGAN CHASE BANK 7H6GLXDRUGQFU57RNE97 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N MFS Service Center, Inc. 084-01316 SEC identifier Y N N MASSACHUSETTS FINANCIAL SERVICES 1G3OSH3GLGJ7X1JC5I61 Y N N Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 424.30000000 Berenberg Capital Markets LLC 8-68821 000156757 5493007EG0CYRKKG9L11 299.81000000 Citigroup Global Markets Inc. 8-08177 000007059 MBNUM2BPBDO7JBLYG310 670.91000000 Merrill Lynch, Pierce, Fenner & Smith Inc. 8-07221 000007691 8NAV47T0Y26Q87Y0QP81 777.52000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 550.23000000 BofA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 264.79000000 Jefferies LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 637.21000000 Credit Suisse Securities (USA) LLC 8-00422 000000816 1V8Y6QCX6YMJ2OELII46 299.58000000 Goldman Sachs & Co. LLC 8-00129 000000361 FOR8UP27PHTHYVLBNG30 624.46000000 BNP Paribas Securities Corp. 8-32682 000015794 RCNB6OTYUAMMP879YW96 583.16000000 6702.61000000 Wells Fargo Securities, LLC 8-65876 000126292 VYVVCKR63DVZZN70PB21 669315.84000000 Nomura Securities International, Inc. 8-15255 000004297 OXTKY6Q8X53C9ILVV871 531617.97000000 BNP Paribas Securities Corp. 8-32682 000015794 RCNB6OTYUAMMP879YW96 921722.44000000 Societe Generale N/A N/A O2RNE8IBXP4R0TD8PU41 FR 1210595.65000000 Goldman Sachs & Co. LLC 8-00129 000000361 FOR8UP27PHTHYVLBNG30 821544.89000000 Citigroup Global Markets Inc. 8-08177 000007059 MBNUM2BPBDO7JBLYG310 3481030.08000000 Deutsche Bank Securities Inc. 8-17822 000002525 9J6MBOOO7BECTDTUZW19 2997864.28000000 BofA Securities, Inc. 8-69787 000283942 549300HN4UKV1E2R3U73 702261.50000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 2230825.82000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 3700911.22000000 18800386.63000000 Y 45837736.79000000 Uncommitted 200000000.00000000 N Uncommitted 100000000.00000000 N Committed 1250000000.00000000 N N N N false false true false false false INTERNAL CONTROL RPT 2 Audit_Letter_Series_Trust.txt AUDIT LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Trustees of MFS Series Trust XVI and the Shareholders of MFS Prudent Investor Fund: In planning and performing our audit of the financial statements of MFS Prudent Investor Fund (the Fund) as of and for the year ended June 30, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinions on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A funds internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A funds internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management of the fund and trustees of the trust; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a funds assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a funds annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Funds internal control over financial reporting and its operations, including controls for safeguarding securities, that we consider to be a material weakness, as defined above, as of June 30, 2021. This report is intended solely for the information and use of management, the Board of Trustees of MFS Series Trust XVI and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. DELOITTE & TOUCHE LLP Boston, Massachusetts August 13, 2021